BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29

• Press Releases

  BioSig Technologies, Inc. & Streamex Announce Closing of $15 Million Public Offering

  August 18, 2025

   · 

  4 min read
• Press Releases

  Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - August 15, 2025

  August 18, 2025

   · 

  1 min read
• Press Releases

  Novo Nordisk A/S: Wegovy® approved in the US for the treatment of MASH

  August 18, 2025

   · 

  4 min read
• Press Releases

  Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - August 15, 2025

  August 18, 2025

   · 

  3 min read
• Press Releases

  Ryght AI Partners with Global CRO Biorasi to Deliver AI-Powered Feasibility Solutions to Biotech and Biopharma Sponsors

  August 18, 2025

   · 

  4 min read
• Press Releases

  Wegovy® approved by FDA for the treatment of adults with noncirrhotic MASH with moderate to advanced liver fibrosis

  August 18, 2025

   · 

  15 min read
• Press Releases

  Quest Diagnostics to Speak at the Baird 2025 Global Healthcare Conference

  August 18, 2025

   · 

  1 min read
• Press Releases

  Ascentage Pharma Announces Global Registrational Phase III Study of Lisaftoclax for First-line Treatment of Patients with Higher-Risk Myelodysplastic Syndrome Cleared by US FDA and EMA

  August 18, 2025

   · 

  11 min read
• Press Releases

  Ascletis Announces the Combination of ASC47 and ASC31, its Dual GLP-1R/GIPR Peptide Agonist, Demonstrated Significantly Greater Weight Loss Compared to the Combination of ASC47 and Tirzepatide in an Animal Model of Obesity

  August 18, 2025

   · 

  3 min read
• Press Releases

  New Novartis ESC data highlights strength of cardiovascular portfolio

  August 18, 2025

   · 

  6 min read